References
- 1. Torino F, Bonmassar E, Bonmassar L, Vecchis L De, Barnabei A, Zuppi C, et al. Circulating tumor cells in colorectal cancer patients. Cancer Treat Rev. 2013;39(7):759-72. DOI: 10.1016/j.ctrv.2012.12.00710.1016/j.ctrv.2012.12.00723375250
- 2. Dalum G Van, Stam G, Scholten LFA, Mastboom WJB. Importance of circulating tumor cells in newly diagnosed colorectal cancer. Int J Oncol. 2015;46:1361-8. DOI: 10.3892/ijo.2015.282410.3892/ijo.2015.282425572133
- 3. Maestro LM, Sastre J, Rafael SB, Veganzones SB, Vidaurreta M, Martín M, et al. Circulating Tumor Cells in Solid Tumor in Metastatic and Localized Stages. 2009;4844:4839-43.
- 4. Venesio T, Siravegna G, Bardelli A, Sapino A. Liquid Biopsies for Monitoring Temporal Genomic Heterogeneity in Breast and Colon Cancers. Pathobiology. 2018;85(1-2):146-54. DOI: 10.1159/00047388210.1159/00047388228614831
- 5. Sundling KE, Lowe AC. Circulating Tumor Cells : Overview and Opportunities in Cytology. Adv Anat Pathol. 2019 Jan;26(1):56-63.2019;26(1):56-63. DOI: 10.1097/PAP.000000000000021710.1097/PAP.000000000000021730325755
- 6. Katsuno H, Zacharakis E, Aziz O, Ziprin P, Athanasiou T, Darzi A. Does the Presence of Circulating Tumor Cells in the Venous Drainage of Curative Colorectal Cancer Resections Determine Prognosis ? A Meta-Analysis. Ann Surg Oncol. 2008;15(11):3083-91. DOI: 10.1245/s10434-008-0131-810.1245/s10434-008-0131-818787906
- 7. Rahbari NN, Aigner M, Thorlund K, Mollberg N, Motschall E, Jensen K, et al. Meta-analysis Shows That Detection of Circulating Tumor Cells Indicates Poor Prognosis in Patients With Colorectal Cancer. Gastroenterology. 2010;138(5):1714-26. DOI: 10.1053/j.gastro.2010.01.00810.1053/j.gastro.2010.01.00820100481
- 8. Lu Y, Wang P, Peng J, Wang X, Zhu Y, Shen N. Meta-analysis Reveals the Prognostic Value of Circulating Tumour Cells Detected in the Peripheral Blood in Patients with Non-Metastatic Colorectal Cancer. Sci Rep. 2017 Apr 19;7(1):905. DOI: 10.1038/s41598-017-01066-y10.1038/s41598-017-01066-y543045728424486
- 9. Tan Y, Wu H. The significant prognostic value of circulating tumor cells in colorectal cancer: A systematic review and meta-analysis. Curr Probl Cancer. 2018 Jan-Feb;42(1):95-106. DOI: 10.1016/j.currproblcancer.2017.11.00210.1016/j.currproblcancer.2017.11.00229277243
- 10. Sastre J, Maestro ML, Puente J, Veganzones S, Alfonso R, Rafael S, et al. Circulating tumor cells in colorectal cancer : correlation with clinical and pathological variables. Ann Oncol. 2008 May;19(5):935-8. DOI: 10.1093/annonc/mdm58310.1093/annonc/mdm58318212090
- 11. Peach G, Kim C, Zacharakis E, Purkayastha S, Ziprin P. Prognostic significance of circulating tumour cells following surgical resection of colorectal cancers: a systematic review. Br J Cancer. 2010;102(9):1327-34. DOI: 10.1038/sj.bjc.660565110.1038/sj.bjc.6605651286576020389297
- 12. Sales J, Wind P, Douard R. Blood dissemination of colonic epithelial cells during no-touch surgery for rectosigmoid cancer. Lancet. 1999 Jul 31;354(9176):392. DOI: 10.1016/S0140-6736(99)92164-510.1016/S0140-6736(99)92164-5
- 13. Chen WS, Chung MY, Liu JH, Liu JM, Lin JK. Impact of circulating free tumor cells in the peripheral blood of colorectal cancer patients during laparoscopic surgery. World J Surg. 2004;28(6):552-7. DOI: 10.1007/s00268-004-7276-910.1007/s00268-004-7276-915366744
- 14. Ramdane Harouakaa, Zhigang Kangb, Siyang Zhenga and LC. Circulating tumor cells: advances in isolation and analysis, and challenges for clinical applications. Pharmacol Ther. 2014 Feb; 141(2): 209-221. DOI: 10.1016/j.pharmthera.2013.10.00410.1016/j.pharmthera.2013.10.004394724724134902
- 15. Vaiopoulos AG, Kostakis ID, Gkioka E, Christopoulos P, Gogas H, Kouraklis G, et al. Detection of Circulating Tumor Cells in Colorectal and Gastric Cancer Using a Multiplex PCR Assay. Anticancer research. 2014;34(6):3083-92.
- 16. Assay T, Luca A De, Pignata S, Casamassimi A, Antonio AD, Gridelli C, et al. Detection of Circulating Tumor Cells in Carcinoma Patients by a Novel Epidermal Growth Factor Receptor Reverse. Clin Cancer Res. 2000;6:1439-44.
- 17. Thorsteinsson M, Jess P. The clinical significance of circulating tumor cells in non-metastatic colorectal cancer e A review. Eur J Surg Oncol. 2011;37(6):459-65. DOI: 10.1016/j.ejso.2011.01.02510.1016/j.ejso.2011.01.02521324632
- 18. Huang X, Gao P, Song Y, Sun J, Chen X, Zhao J, et al. Meta-analysis of the prognostic value of circulating tumor cells detected with the CellSearch System in colorectal cancer. BMC Cancer. 2015;15:202. DOI: 10.1186/s12885-015-1218-910.1186/s12885-015-1218-9438931125880692
- 19. Mund JA, Estes ML, Yoder MC, Ingram DA Jr, Case J. Flow cytometric identification and functional characterization of immature and mature circulating endothelial cells. Arterioscler Thromb Vasc Biol. 2012;32(4):1045-1053. DOI: 10.1161/ATVBAHA.111.24421010.1161/ATVBAHA.111.244210330652922282356
- 20. Duda DG, Cohen KS, Scadden DT, Jain RK. A protocol for phenotypic detection and numeration of circulating endothelial cells and circulating progenitor cells in human blood. Nat Protoc. 2007;2(4):805-10. DOI: 10.1038/nprot.2007.11110.1038/nprot.2007.111268612517446880
- 21. Huang X, Gao P, Song Y, Sun J, Chen X, Zhao J, et al. Relationship between circulating tumor cells and tumor response in colorectal cancer patients treated with chemotherapy: a meta-analysis. BMC Cancer. 2014;14:976. DOI: 10.1186/1471-2407-14-97610.1186/1471-2407-14-976430214825519477
- 22. Sun W, Li G, Wan J, Zhu J, Shen W, Zhang Z. Circulating tumor cells : A promising marker of predicting tumor response in rectal cancer patients receiving neoadjuvant chemo-radiation therapy. Oncotarget. 2016;7(43):69507-17. DOI: 10.18632/oncotarget.1087510.18632/oncotarget.10875534249427486758
- 23. Bünger S, Zimmermann M, Habermann JK. Diversity of assessing circulating tumor cells (CTCs) emphasizes need for standardization: a CTC Guide to design and report trials. Cancer Metastasis Rev. 2015;34(3):527-45. DOI: 10.1007/s10555-015-9582-010.1007/s10555-015-9582-026323491
- 24. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. BMJ. 2009;339(7716):332-6. DOI: 10.1136/bmj.b253510.1136/bmj.b2535271465719622551
- 25. Fang C, Fan C, Wang C, Huang Q, Meng W, Yu Y, et al. Prognostic value of CD133+ CD54+ CD44+ circulating tumor cells in colorectal cancer with liver metastasis. Cancer Med. 2017;6(12):2850-57. DOI: 10.1002/cam4.124110.1002/cam4.1241572729929105339
- 26. Galizia G, Gemei M, Orditura M, Romano C, Zamboli A, Castellano P, et al. Postoperative Detection of Circulating Tumor Cells Predicts Tumor Recurrence in Colorectal Cancer Patients. J Gastrointest Surg. 2013;17(10):1809-18. DOI: 10.1007/s11605-013-2258-610.1007/s11605-013-2258-623813048
- 27. Tralhao, J.G Hoti, E, Serdio, M Laranjeiro P, Paiva A, Abrantes AM, Hoti E, Sero M. Perioperative tumor cell dissemination in patients with primary or metastatic colorectal cancer. Eur J Surg Oncol. 2010;36(2):125-9. DOI: 10.1016/j.ejso.2009.07.00310.1016/j.ejso.2009.07.00319646840
- 28. Cohen SJ, Alpaugh RK, Gross S, Hara SMO, Smirnov DA, Terstappen LWMM, et al. Isolation and Characterization of Circulating Tumor Cells in Patients with Metastatic Colorectal Cancer. Clin Colorectal Cancer. 2006;6(2):125-32. DOI: 10.3816/CCC.2006.n.02910.3816/CCC.2006.n.02916945168
- 29. Tseng J, Yang C, Liang S, Liu R, Yang S, Lin J. Inter-leukin-17A Modulates Circulating Tumor Cells in Tumor Draining Vein of Colorectal Cancers and Affects Metastases. Clin Cancer Res. 2014;20(11):2885-97. DOI: 10.1158/1078-0432.CCR-13-216210.1158/1078-0432.CCR-13-216224677375
- 30. Tsavellas G, Huang A, Mccullough T, Patel H, Araia R. Flow cytometry correlates with RT-PCR for detection of spiked but not circulating colorectal cancer cells. Clin Exp Metastasis. 2002;19(6):495-502. DOI: 10.1023/A:102035011729210.1023/A:1020350117292
- 31. Bahnassy AA, Salem SE, Mohanad M, Abulezz NZ, Abdellateif MS, Hussein M, et al. Prognostic significance of circulating tumor cells (CTCs) in Egyptian non- metastatic colorectal cancer patients: A comparative study for four di ff erent techniques of detection (Flowcytometry, CellSearch, Quantitative Real-time PCR and Cytomorpholoqy). Exp Mol Pathol. 2019;106:90-101. DOI: 10.1016/j.yexmp.2018.12.00610.1016/j.yexmp.2018.12.00630578762
- 32. Aghagolzadeh P, Radpour R. New trends in molecular and cellular biomarker discovery for colorectal cancer. World J Gastroenterol. 2016;22(25):5678-93. DOI: 10.3748/wjg.v22.i25.567810.3748/wjg.v22.i25.5678493220527433083
- 33. Denis JA, Lacorte J-M. Detection of RAS mutations in circulating tumor cells: applications in colorectal cancer and prospects. Ann Biol Clin (Paris). 2017;75(6):607-18. DOI: 10.1684/abc.2017.130410.1684/abc.2017.130429192596
- 34. Tsavellas G, Patel H, Allen-Mersh TG. Detection and clinical significance of occult tumour cells in colorectal cancer. Br J Surg. 2001;88(10):1307-20. DOI: 10.1046/j.0007-1323.2001.01863.x10.1046/j.0007-1323.2001.01863.x11578283
- 35. Wang L, Wang Y, Liu Y, Cheng M, Wu X, Wei H. Flow cytometric analysis of CK19 expression in the peripheral blood of breast carcinoma patients: relevance for circulating tumor cell detection. J Exp Clin Cancer Res. 2009;28(1):57. DOI: 10.1186/1756-9966-28-5710.1186/1756-9966-28-57268512419397830
- 36. Lopez A, Harada K, Mizrak Kaya D, Dong X, Song S, Ajani JA. Liquid biopsies in gastrointestinal malignancies: when is the big day? Expert Rev Anticancer Ther. 2018;18(1):19-38. DOI: 10.1080/14737140.2018.140332010.1080/14737140.2018.140332029202614
- 37. Malara N, Trunzo V, Foresta U, Amodio N, Vitis S De, Roveda L. Ex vivo characterization of circulating colon cancer cells distinguished in stem and differentiated subset provides useful biomarker for personalized metastatic risk assessment. J Transl Med. 2016;14(1):133. DOI: 10.1186/s12967-016-0876-y10.1186/s12967-016-0876-y486643627176720
- 38. Vlems FA, Diepstra JHS, Cornelissen IMHA, Ruers TJM, Ligtenberg MJL, Punt CJA, et al. Limitations of cytokeratin 20 RT-PCR to detect disseminated tumour cells in blood and bone marrow of patients with colorectal cancer: expression in controls and downregulation in tumour tissue. J Clin Pathol - Mol Pathol. 2002;55(3):156-63. DOI: 10.1136/mp.55.3.15610.1136/mp.55.3.156118716812032226
- 39. Søreide K, Watson MM, Lea D, Nordgård O, Søreide JA, Hagland HR. Assessment of clinically related outcomes and biomarker analysis for translational integration in colorectal cancer (ACROBATICC): Study protocol for a population-based, consecutive cohort of surgically treated colorectal cancers and resected colorectal liver metastasis. J Transl Med. 2016;14(1):192. DOI: 10.1186/s12967-016-0951-410.1186/s12967-016-0951-4492827627357108
- 40. Chou WC, Wu MH, Chang PH, Hsu HC, Chang GJ, Huang WK, et al. A prognostic model based on circulating tumour cells is useful for identifying the poorest survival outcome in patients with metastatic colorectal cancer. Int J Biol Sci. 2018;14(2):137-46. DOI: 10.7150/ijbs.2318210.7150/ijbs.23182582103529483832
- 41. Connor AA, McNamara K, Al-Sukhni E, Diskin J, Chan D, Ash C, et al. Central, But Not Peripheral, Circulating Tumor Cells are Prognostic in Patients Undergoing Resection of Colorectal Cancer Liver Metastases. Ann Surg Oncol. 2016;23(7):2168-75. DOI: 10.1245/s10434-015-5038-610.1245/s10434-015-5038-626714949
- 42. Rahbari NN, Bork U, Kircher A, Nimitz T, Schölch S, Kahlert C, et al. Compartmental differences of circulating tumor cells in colorectal cancer. Ann Surg Oncol. 2012;19(7):2195-202. DOI: 10.1245/s10434-011-2178-110.1245/s10434-011-2178-122230943
- 43. Gogenur M, Hillig T, Gogenur I. CytoTrack analysis reveals low presence of circulating tumor cells in the perioperative period in patients with non-metastatic colorectal cancer. Anticancer Res. 2017;37(6):3099-103. DOI: 10.21873/anticanres.1166610.21873/anticanres.1166628551650
- 44. Tsai WS, Chen JS, Shao HJ, Wu JC, Lai JM, Lu SH, et al. Circulating Tumor Cell Count Correlates with Colorectal Neoplasm Progression and Is a Prognostic Marker for Distant Metastasis in Non-Metastatic Patients. Sci Rep. 2016;6(3):4-11. DOI: 10.1038/srep2451710.1038/srep24517483094927075165
- 45. Wu W, Zhang Z, Gao XH, Shen Z, Jing Y, Lu H, et al. Clinical significance of detecting circulating tumor cells in colorectal cancer using subtraction enrichment and immunostainingfluorescence in situ hybridization (SE-iFISH). Oncotarget. 2017;8(13):21639-49. DOI: 10.18632/oncotarget.1545210.18632/oncotarget.15452540061228423493
- 46. Bosch B, Guller U, Schnider A, Maurer R, Harder F, Metzger U, et al. Perioperative detection of disseminated tumour cells is an independent prognostic factor in patients with colorectal cancer. Br J Surg. 2003;90(7):882-8. DOI: 10.1002/bjs.412910.1002/bjs.412912854118
- 47. Seeberg LT, Brunborg C, Waage A, Hugenschmidt H, Renolen A, Stav I, et al. Survival Impact of Primary Tumor Lymph Node Status and Circulating Tumor Cells in Patients with Colorectal Liver Metastases. Ann Surg Oncol. 2017;24(8):2113-21. DOI: 10.1245/s10434-017-5818-210.1245/s10434-017-5818-2549163028258416
- 48. Wind J, Tuynman JB, Tibbe AGJ, Swennenhuis JF, Richel DJ. Circulating tumour cells during laparoscopic and open surgery for primary colonic cancer in portal and peripheral blood. Eur J Surg Oncol. 2009;35(9):942-50. DOI: 10.1016/j.ejso.2008.12.00310.1016/j.ejso.2008.12.00319153024
- 49. Abalde-cela S, Piairo P. The Significance of Circulating Tumour Cells in the Clinic. Acta Cytol. 2019:1-13. DOI: 10.1159/00049541710.1159/00049541730820013
- 50. Schmidt T, Koch M, Antolovic D, Reissfelder C, Schmitz-winnenthal FH, Rahbari NN, et al. Influence of two different resection techniques (conventional liver resection versus anterior approach) of liver metastases from colorectal cancer on hematogenous tumor cell dissemination - prospective randomized multicenter trial. BMC Surg. 2008;8:6. DOI: 10.1186/1471-2482-8-610.1186/1471-2482-8-6229214618321372
- 51. Groot Koerkamp B, Rahbari NN, Büchler MW, Koch M, Weitz J. Circulating tumor cells and prognosis of patients with resectable colorectal liver metastases or widespread metastatic colorectal cancer: A meta-analysis. Ann Surg Oncol. 2013;20(7):2156-65. DOI: 10.1245/s10434-013-2907-810.1245/s10434-013-2907-823456317